Literature DB >> 32962802

Identification of Key circRNAs in Non-Small Cell Lung Cancer.

Lei Li1, Daqiang Sun2, Xiaoping Li3, Bo Yang3, Weidong Zhang3.   

Abstract

BACKGROUND: Our work aimed to identify the key differentially expressed circular RNAs (circRNAs) (DECs) in non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: An integrated analysis based on public NSCLC datasets obtained from Gene Expression Omnibus was performed. DECs in NSCLC were subsequently identified. Bioinformatics analyses were utilized for describing the predictable functions of DECs including circRNA-miRNA network construction and pathway enrichment. The diagnostic value of candidate DECs among NSCLC and healthy individuals were preliminarily evaluated in GSE101586, GSEE101684, GSE112214 datasets.
RESULTS: A total of 43 up-regulated and 78 down-regulated DECs in NSCLC were identified. The mTOR signaling pathway, ErbB signaling pathway and cell cycle were significantly enriched from the originated genes of DECs in NSCLC. In the circRNA-miRNA network, hsa-circ-0002702, hsa-circ-0049271, hsa-circ-0009150 and hsa-circ-0053958 had high connectivity with miRNAs, which respectively interacted with 122, 42, 41, and 39 miRNAs. hsa_circ_0003028, hsa_circ_0015278, hsa_circ_0043256, hsa_circ_0049657 and hsa_circ_0074930 could distinguish NSCLC patients from healthy individuals in GSE101586, GSEE101684, GSE112214 datasets.
CONCLUSIONS: DECs including hsa_circ_0003028, hsa_circ_0015278, hsa_circ_0043256, hsa_circ_0049657 and hsa_circ_0074930 had diagnostic value in NSCLC. These DECs might play key roles in NSCLC pathogenesis through the mTOR signaling pathway, ErbB signaling pathway and cell cycle.
Copyright © 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Non-small cell lung cancer; Pathogenesis.; circRNA

Year:  2020        PMID: 32962802     DOI: 10.1016/j.amjms.2020.08.008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  13 in total

1.  Circ_0030998 Restrains Cisplatin Resistance Through Mediating miR-1323/PDCD4 Axis in Non-small Cell Lung Cancer.

Authors:  Changyu Zhu; Xiaolei Jiang; Hua Xiao; Jianmei Guan
Journal:  Biochem Genet       Date:  2022-04-23       Impact factor: 1.890

2.  Circ_0016760 Serves as a Cancer Promoter in Non-small Cell Lung Cancer Through miR-876-3p/NOVA2 Axis.

Authors:  Fengjie Liu; Haiying Gao; Mingwei Chen; Anqi Li; Ting Liu
Journal:  Biochem Genet       Date:  2022-03-03       Impact factor: 1.890

3.  Circular RNA _0015278 inhibits the progression of non-small cell lung cancer through regulating the microRNA 1278/SOCS6 gene axis.

Authors:  Yiwang Ye; Xuan Wu; Feihu Long; Wei Yue; Da Wu; Yuancai Xie
Journal:  Ann Transl Med       Date:  2021-08

4.  Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer.

Authors:  Qiuwen Sun; Xia Li; Muchen Xu; Li Zhang; Haiwei Zuo; Yong Xin; Longzhen Zhang; Ping Gong
Journal:  Front Genet       Date:  2020-11-24       Impact factor: 4.599

5.  Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Authors:  Qi Shao; Yong Huang; Cai Zhang; Xiaochan Gao; Shiyang Gao
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

6.  A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.

Authors:  Daping Fan; Yue Yang; Wei Zhang
Journal:  BMC Pulm Med       Date:  2022-01-07       Impact factor: 3.317

Review 7.  Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer.

Authors:  Ying Liu; Xiang Ao; Wanpeng Yu; Yuan Zhang; Jianxun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

8.  Identification of Differentially Expressed Circular RNAs as miRNA Sponges in Lung Adenocarcinoma.

Authors:  Yuechao Liu; Xin Wang; Lulu Bi; Hongbo Huo; Shi Yan; Yimeng Cui; Yaowen Cui; Ruixue Gu; Dexin Jia; Shuai Zhang; Li Cai; Xiaomei Li; Ying Xing
Journal:  J Oncol       Date:  2021-09-10       Impact factor: 4.375

9.  Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma.

Authors:  Yi He; Haiting Zhou; Wei Wang; Haoran Xu; Hao Cheng
Journal:  Front Genet       Date:  2021-05-17       Impact factor: 4.599

10.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.